Global and China Pneumonia Diagnostic Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pneumonia Diagnostic Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Streptococcus-based
1.2.3 Legionella-based
1.2.4 Chlamydophila-based
1.2.5 Viral Pneumonia-based
1.2.6 Mycoplasma Pneumonia-based
1.3 Market by Application
1.3.1 Global Pneumonia Diagnostic Market Share by Application: 2020 VS 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Diagnostic Centres
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pneumonia Diagnostic Market Perspective (2015-2026)
2.2 Global Pneumonia Diagnostic Growth Trends by Regions
2.2.1 Pneumonia Diagnostic Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Pneumonia Diagnostic Historic Market Share by Regions (2015-2020)
2.2.3 Pneumonia Diagnostic Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pneumonia Diagnostic Players by Market Size
3.1.1 Global Top Pneumonia Diagnostic Players by Revenue (2015-2020)
3.1.2 Global Pneumonia Diagnostic Revenue Market Share by Players (2015-2020)
3.2 Global Pneumonia Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pneumonia Diagnostic Revenue
3.4 Global Pneumonia Diagnostic Market Concentration Ratio
3.4.1 Global Pneumonia Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pneumonia Diagnostic Revenue in 2019
3.5 Key Players Pneumonia Diagnostic Area Served
3.6 Key Players Pneumonia Diagnostic Product Solution and Service
3.7 Date of Enter into Pneumonia Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pneumonia Diagnostic Breakdown Data by Type (2015-2026)
4.1 Global Pneumonia Diagnostic Historic Market Size by Type (2015-2020)
4.2 Global Pneumonia Diagnostic Forecasted Market Size by Type (2021-2026)
5 Pneumonia Diagnostic Breakdown Data by Application (2015-2026)
5.1 Global Pneumonia Diagnostic Historic Market Size by Application (2015-2020)
5.2 Global Pneumonia Diagnostic Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Pneumonia Diagnostic Market Size (2015-2026)
6.2 North America Pneumonia Diagnostic Market Size by Type (2015-2020)
6.3 North America Pneumonia Diagnostic Market Size by Application (2015-2020)
6.4 North America Pneumonia Diagnostic Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Pneumonia Diagnostic Market Size (2015-2026)
7.2 Europe Pneumonia Diagnostic Market Size by Type (2015-2020)
7.3 Europe Pneumonia Diagnostic Market Size by Application (2015-2020)
7.4 Europe Pneumonia Diagnostic Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Pneumonia Diagnostic Market Size (2015-2026)
8.2 China Pneumonia Diagnostic Market Size by Type (2015-2020)
8.3 China Pneumonia Diagnostic Market Size by Application (2015-2020)
8.4 China Pneumonia Diagnostic Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Pneumonia Diagnostic Market Size (2015-2026)
9.2 Japan Pneumonia Diagnostic Market Size by Type (2015-2020)
9.3 Japan Pneumonia Diagnostic Market Size by Application (2015-2020)
9.4 Japan Pneumonia Diagnostic Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Pneumonia Diagnostic Market Size (2015-2026)
10.2 Southeast Asia Pneumonia Diagnostic Market Size by Type (2015-2020)
10.3 Southeast Asia Pneumonia Diagnostic Market Size by Application (2015-2020)
10.4 Southeast Asia Pneumonia Diagnostic Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Pneumonia Diagnostic Introduction
11.1.4 Abbott Revenue in Pneumonia Diagnostic Business (2015-2020))
11.1.5 Abbott Recent Development
11.2 Glaxo Smith Kline
11.2.1 Glaxo Smith Kline Company Details
11.2.2 Glaxo Smith Kline Business Overview
11.2.3 Glaxo Smith Kline Pneumonia Diagnostic Introduction
11.2.4 Glaxo Smith Kline Revenue in Pneumonia Diagnostic Business (2015-2020)
11.2.5 Glaxo Smith Kline Recent Development
11.3 Affymetrix
11.3.1 Affymetrix Company Details
11.3.2 Affymetrix Business Overview
11.3.3 Affymetrix Pneumonia Diagnostic Introduction
11.3.4 Affymetrix Revenue in Pneumonia Diagnostic Business (2015-2020)
11.3.5 Affymetrix Recent Development
11.4 Becton Dickinson
11.4.1 Becton Dickinson Company Details
11.4.2 Becton Dickinson Business Overview
11.4.3 Becton Dickinson Pneumonia Diagnostic Introduction
11.4.4 Becton Dickinson Revenue in Pneumonia Diagnostic Business (2015-2020)
11.4.5 Becton Dickinson Recent Development
11.5 BioMerieux
11.5.1 BioMerieux Company Details
11.5.2 BioMerieux Business Overview
11.5.3 BioMerieux Pneumonia Diagnostic Introduction
11.5.4 BioMerieux Revenue in Pneumonia Diagnostic Business (2015-2020)
11.5.5 BioMerieux Recent Development
11.6 Cepheid
11.6.1 Cepheid Company Details
11.6.2 Cepheid Business Overview
11.6.3 Cepheid Pneumonia Diagnostic Introduction
11.6.4 Cepheid Revenue in Pneumonia Diagnostic Business (2015-2020)
11.6.5 Cepheid Recent Development
11.7 Diamedix/Erba
11.7.1 Diamedix/Erba Company Details
11.7.2 Diamedix/Erba Business Overview
11.7.3 Diamedix/Erba Pneumonia Diagnostic Introduction
11.7.4 Diamedix/Erba Revenue in Pneumonia Diagnostic Business (2015-2020)
11.7.5 Diamedix/Erba Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Pneumonia Diagnostic Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Streptococcus-based
Table 4. Key Players of Legionella-based
Table 5. Key Players of Chlamydophila-based
Table 6. Key Players of Viral Pneumonia-based
Table 7. Key Players of Mycoplasma Pneumonia-based
Table 8. Global Pneumonia Diagnostic Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Pneumonia Diagnostic Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Pneumonia Diagnostic Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Pneumonia Diagnostic Market Share by Regions (2015-2020)
Table 12. Global Pneumonia Diagnostic Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Pneumonia Diagnostic Market Share by Regions (2021-2026)
Table 14. Pneumonia Diagnostic Market Market Trends
Table 15. Pneumonia Diagnostic Market Drivers
Table 16. Pneumonia Diagnostic Market Challenges
Table 17. Pneumonia Diagnostic Market Restraints
Table 18. Global Pneumonia Diagnostic Revenue by Players (2015-2020) (US$ Million)
Table 19. Global Pneumonia Diagnostic Market Share by Players (2015-2020)
Table 20. Global Top Pneumonia Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumonia Diagnostic as of 2019)
Table 21. Global Pneumonia Diagnostic by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Pneumonia Diagnostic Product Solution and Service
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pneumonia Diagnostic Market Size by Type (2015-2020) (US$ Million)
Table 26. Global Pneumonia Diagnostic Market Size Share by Type (2015-2020)
Table 27. Global Pneumonia Diagnostic Revenue Market Share by Type (2021-2026)
Table 28. Global Pneumonia Diagnostic Market Size Share by Application (2015-2020)
Table 29. Global Pneumonia Diagnostic Market Size by Application (2015-2020) (US$ Million)
Table 30. Global Pneumonia Diagnostic Market Size Share by Application (2021-2026)
Table 31. North America Pneumonia Diagnostic Market Size by Type (2015-2020) (US$ Million)
Table 32. North America Pneumonia Diagnostic Market Share by Type (2015-2020)
Table 33. North America Pneumonia Diagnostic Market Size by Application (2015-2020) (US$ Million)
Table 34. North America Pneumonia Diagnostic Market Share by Application (2015-2020)
Table 35. North America Pneumonia Diagnostic Market Size by Country (US$ Million) (2015-2020)
Table 36. North America Pneumonia Diagnostic Market Share by Country (2015-2020)
Table 37. Europe Pneumonia Diagnostic Market Size by Type (2015-2020) (US$ Million)
Table 38. Europe Pneumonia Diagnostic Market Share by Type (2015-2020)
Table 39. Europe Pneumonia Diagnostic Market Size by Application (2015-2020) (US$ Million)
Table 40. Europe Pneumonia Diagnostic Market Share by Application (2015-2020)
Table 41. Europe Pneumonia Diagnostic Market Size by Country (US$ Million) (2015-2020)
Table 42. Europe Pneumonia Diagnostic Market Share by Country (2015-2020)
Table 43. China Pneumonia Diagnostic Market Size by Type (2015-2020) (US$ Million)
Table 44. China Pneumonia Diagnostic Market Share by Type (2015-2020)
Table 45. China Pneumonia Diagnostic Market Size by Application (2015-2020) (US$ Million)
Table 46. China Pneumonia Diagnostic Market Share by Application (2015-2020)
Table 47. China Pneumonia Diagnostic Market Size by Region (US$ Million) (2015-2020)
Table 48. China Pneumonia Diagnostic Market Share by Region (2015-2020)
Table 49. Japan Pneumonia Diagnostic Market Size by Type (2015-2020) (US$ Million)
Table 50. Japan Pneumonia Diagnostic Market Share by Type (2015-2020)
Table 51. Japan Pneumonia Diagnostic Market Size by Application (2015-2020) (US$ Million)
Table 52. Japan Pneumonia Diagnostic Market Share by Application (2015-2020)
Table 53. Japan Pneumonia Diagnostic Market Size by Country (US$ Million) (2015-2020)
Table 54. Japan Pneumonia Diagnostic Market Share by Country (2015-2020)
Table 55. Southeast Asia Pneumonia Diagnostic Market Size by Type (2015-2020) (US$ Million)
Table 56. Southeast Asia Pneumonia Diagnostic Market Share by Type (2015-2020)
Table 57. Southeast Asia Pneumonia Diagnostic Market Size by Application (2015-2020) (US$ Million)
Table 58. Southeast Asia Pneumonia Diagnostic Market Share by Application (2015-2020)
Table 59. Southeast Asia Pneumonia Diagnostic Market Size by Country (US$ Million) (2015-2020)
Table 60. Southeast Asia Pneumonia Diagnostic Market Share by Country (2015-2020)
Table 61. Abbott Company Details
Table 62. Abbott Business Overview
Table 63. Abbott Product
Table 64. Abbott Revenue in Pneumonia Diagnostic Business (2015-2020) (US$ Million)
Table 65. Abbott Recent Development
Table 66. Glaxo Smith Kline Company Details
Table 67. Glaxo Smith Kline Business Overview
Table 68. Glaxo Smith Kline Product
Table 69. Glaxo Smith Kline Revenue in Pneumonia Diagnostic Business (2015-2020) (US$ Million)
Table 70. Glaxo Smith Kline Recent Development
Table 71. Affymetrix Company Details
Table 72. Affymetrix Business Overview
Table 73. Affymetrix Product
Table 74. Affymetrix Revenue in Pneumonia Diagnostic Business (2015-2020) (US$ Million)
Table 75. Affymetrix Recent Development
Table 76. Becton Dickinson Company Details
Table 77. Becton Dickinson Business Overview
Table 78. Becton Dickinson Product
Table 79. Becton Dickinson Revenue in Pneumonia Diagnostic Business (2015-2020) (US$ Million)
Table 80. Becton Dickinson Recent Development
Table 81. BioMerieux Company Details
Table 82. BioMerieux Business Overview
Table 83. BioMerieux Product
Table 84. BioMerieux Revenue in Pneumonia Diagnostic Business (2015-2020) (US$ Million)
Table 85. BioMerieux Recent Development
Table 86. Cepheid Company Details
Table 87. Cepheid Business Overview
Table 88. Cepheid Product
Table 89. Cepheid Revenue in Pneumonia Diagnostic Business (2015-2020) (US$ Million)
Table 90. Cepheid Recent Development
Table 91. Diamedix/Erba Company Details
Table 92. Diamedix/Erba Business Overview
Table 93. Diamedix/Erba Product
Table 94. Diamedix/Erba Revenue in Pneumonia Diagnostic Business (2015-2020) (US$ Million)
Table 95. Diamedix/Erba Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Pneumonia Diagnostic Market Share by Type: 2020 VS 2026
Figure 2. Streptococcus-based Features
Figure 3. Legionella-based Features
Figure 4. Chlamydophila-based Features
Figure 5. Viral Pneumonia-based Features
Figure 6. Mycoplasma Pneumonia-based Features
Figure 7. Global Pneumonia Diagnostic Market Share by Application: 2020 VS 2026
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Diagnostic Centres Case Studies
Figure 11. Other Case Studies
Figure 12. Pneumonia Diagnostic Report Years Considered
Figure 13. Global Pneumonia Diagnostic Market Size (US$ Million), YoY Growth 2015-2026
Figure 14. Global Pneumonia Diagnostic Market Share by Regions: 2020 VS 2026
Figure 15. Global Pneumonia Diagnostic Market Share by Regions (2021-2026)
Figure 16. Global Pneumonia Diagnostic Market Share by Players in 2019
Figure 17. Global Top Pneumonia Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumonia Diagnostic as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Pneumonia Diagnostic Revenue in 2019
Figure 19. North America Pneumonia Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. United States Pneumonia Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Canada Pneumonia Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Europe Pneumonia Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Germany Pneumonia Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. France Pneumonia Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. U.K. Pneumonia Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Italy Pneumonia Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Russia Pneumonia Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Nordic Pneumonia Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Rest of Europe Pneumonia Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Asia-Pacific Pneumonia Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. China Pneumonia Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Japan Pneumonia Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. South Korea Pneumonia Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Southeast Asia Pneumonia Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. India Pneumonia Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Australia Pneumonia Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Rest of Asia-Pacific Pneumonia Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Latin America Pneumonia Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Mexico Pneumonia Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Brazil Pneumonia Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Middle East & Africa Pneumonia Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Turkey Pneumonia Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Saudi Arabia Pneumonia Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. UAE Pneumonia Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. Rest of Middle East & Africa Pneumonia Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 46. Abbott Revenue Growth Rate in Pneumonia Diagnostic Business (2015-2020)
Figure 47. Glaxo Smith Kline Revenue Growth Rate in Pneumonia Diagnostic Business (2015-2020)
Figure 48. Affymetrix Revenue Growth Rate in Pneumonia Diagnostic Business (2015-2020)
Figure 49. Becton Dickinson Revenue Growth Rate in Pneumonia Diagnostic Business (2015-2020)
Figure 50. BioMerieux Revenue Growth Rate in Pneumonia Diagnostic Business (2015-2020)
Figure 51. Cepheid Revenue Growth Rate in Pneumonia Diagnostic Business (2015-2020)
Figure 52. Diamedix/Erba Revenue Growth Rate in Pneumonia Diagnostic Business (2015-2020)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed